Results overview: Found 12 records in 0.02 seconds.
Articles, 12 records found
Articles 12 records found  1 - 10next  jump to record:
1.
16 p, 3.8 MB Genetic and phenotypic attributes of splenic marginal zone lymphoma / Bonfiglio, Ferdinando (Institute of Oncology Research, Bellinzona, Switzerland) ; Bruscaggin, Alessio (Institute of Oncology Research, Bellinzona, Switzerland) ; Guidetti, Francesca (Institute of Oncology Research, Bellinzona, Switzerland) ; Terzi di Bergamo, Lodovico (Institute of Oncology Research, Bellinzona, Switzerland) ; Faderl, Martin (Institute of Oncology Research, Bellinzona, Switzerland) ; Spina, Valeria (Institute of Oncology Research, Bellinzona, Switzerland) ; Condoluci, Adalgisa (Institute of Oncology Research, Bellinzona, Switzerland) ; Bonomini, Luisella (International Extranodal Lymphoma Study Group, Bellinzona, Switzerland) ; Forestieri, Gabriela (Institute of Oncology Research, Bellinzona, Switzerland) ; Koch, Ricardo (Institute of Oncology Research, Bellinzona, Switzerland) ; Piffaretti, Deborah (Institute of Oncology Research, Bellinzona, Switzerland) ; Pini, Katia (Institute of Oncology Research, Bellinzona, Switzerland) ; Pirosa, Maria Cristina (Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Cittone, Micol Giulia (Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Arribas, Alberto (Lymphoma Genomics, Institute of Oncology Research, Bellinzona, Switzerland) ; Lucioni, Marco (Fondazione IRCCS Policlinico San Matteo and Università degli Studi di Pavia, Pavia, Italy) ; Ghilardi, Guido (Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.) ; Wu, Wei (Institute of Oncology Research, Bellinzona, Switzerland) ; Arcaini, Luca (University of Pavia, Pavia, Italy.) ; Baptista, Maria Joao (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Bastidas-Mora, Gabriela (Hospital Clínic i Provincial de Barcelona) ; Bea, Sílvia (Hospital Clínic i Provincial de Barcelona) ; Boldorini, Renzo (University of Eastern Piedmont, Novara, Italy) ; Broccoli, Alessandro (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy.) ; Buehler, Marco Matteo (University Hospital Zurich, Switzerland) ; Canzonieri, Vincenzo (Pathology Unit, CRO Aviano National Cancer Institute, Aviano, Italy) ; Cascione, Luciano (Institute of Oncology Research, Bellinzona, Switzerland) ; Ceriani, Luca (Clinic of Nuclear Medicine and PET-CT Centre, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland) ; Cogliatti, Sergio (Institute of Pathology, Kantonsspital St Gallen, St Gallen, Switzerland) ; Corradini, Paolo (Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy) ; Derenzini, Enrico (European Institute of Oncology (IEO) IRCCS, Milan, Italy) ; Devizzi, Liliana (Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy) ; Dietrich, Sascha (University Hospital Heidelberg, Germany) ; Elia, Angela Rita (Institute of Oncology Research, Bellinzona, Switzerland) ; Facchetti, Fabio (Pathology Unit, Spedali Civili, Brescia, Italy) ; Gaidano, Gianluca (University of Eastern Piedmont, Novara, Italy) ; Garcia, Juan Fernando (MD Anderson Cancer Center, Madrid) ; Gerber, Bernhard (Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Ghia, Paolo (IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy) ; Gomes da Silva, Maria (Instituto Português de Oncologia de Lisboa, Portugal) ; Gritti, Giuseppe (Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy) ; Guidetti, Anna (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy) ; Hitz, Felicitas (Kantonsspital St Gallen, St Gallen, Switzerland) ; Inghirami, Giorgio (Weill Cornell Medical College, New York) ; Ladetto, Marco (Azienda Ospedaliera SS Antonio e Biagio, Alessandria, Italy) ; Lopez-Guillermo, Armando (Hospital Clínic i Provincial de Barcelona) ; Lucchini, Elisa (Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy) ; Maiorana, Antonino (Universitá degli Studi di Modena e Reggio Emilia, Modena, Italy) ; Marasca, Roberto (University of Modena and Reggio Emilia, Modena, Italy) ; Matutes, Estella (Hospital Clínic i Provincial de Barcelona) ; Meignin, Veronique (Saint Louis Hospital, Paris, France) ; Merli, Michele (University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy) ; Moccia, Alden (Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Mollejo, Manuela (Hospital Virgen de la Salud (Toledo)) ; Montalban, Carlos (MD Anderson Cancer Center, Madrid) ; Novak, Urban (University of Bern, Bern, Switzerland) ; Oscier, David Graham (University Hospitals Dorset, Bournemouth, United Kingdom) ; Passamonti, Francesco (University of Insubria) ; Piazza, Francesco (Ospedale Universitario di Padova, Italy) ; Pizzolitto, Stefano (General Hospital S Maria della Misericordia, Udine, Italy) ; Rambaldi, Alessandro (Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy) ; Sabattini, Elena (University of Bologna, Italy) ; Salles, Gilles (Université de Lyon, France) ; Santambrogio, Elisa (Candiolo Cancer Institute (FPO-IRCCS), Candiolo, Turin, Italy) ; Scarfò, Lydia (IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy) ; Stathis, Anastasios (Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Stüssi, Georg (Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Geyer, Julia T. (Weill Cornell Medical College, New York) ; Tapia, G. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Tarella, Corrado (European Institute of Oncology (IEO) IRCCS, Milan, Italy) ; Thieblemont, Catherine (Université de Paris, France) ; Tousseyn, Thomas (University Hospitals Leuven, Belgium) ; Tucci, Alessandra (Spedali Civili, Brescia, Italy.) ; Vanini, Giorgio (University of Bern, Switzerland) ; Visco, Carlo (University of Verona, Italy) ; Vitolo, Umberto (Candiolo Cancer Institute (FPO-IRCCS), Candiolo, Turin, Italy) ; Walewska, Renata (University Hospitals Dorset, Bournemouth, United Kingdom) ; Zaja, Francesco (Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy) ; Zenz, Thorsten (University Hospital Zurich, Switzerland) ; Zinzani, Pier Luigi (Università di Bologna, Italy) ; Khiabanian, Hossein (Rutgers University, New Brunswick) ; Calcinotto, Arianna (Institute of Oncology Research, Bellinzona, Switzerland) ; Bertoni, Francesco (Institute of Oncology Research, Bellinzona, Switzerland) ; Bhagat, Govind (Columbia University, New York, USA) ; Campo, Elias (Hospital Clínic i Provincial de Barcelona) ; de Leval, Laurence (Institut Universitaire de Pathologie, Lausanne, Switzerland) ; Dirnhofer, Stefan (University Hospital Basel, Switzerland) ; Pileri, Stefano A. (European Institute of Oncology IRCCS, Milan, Italy) ; Piris, Miguel Angel (Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid) ; Traverse-Glehen, Alexandra (Centre Hospitalier Lyon Sud, Lyon, France) ; Tzankov, Alexander (University Hospital Basel (Basilea, Suïssa)) ; Paulli, Marco (Fondazione IRCCS Policlinico San Matteo and Università degli Studi di Pavia, Italy) ; Ponzoni, Maurilio (Ateneo Vita-Salute San Raffaele University and Pathology Unit San Raffaele Scientific Institute, Milan, Italy) ; Mazzucchelli, Luca (antonal Institute of Pathology, Locarno, Switzerland) ; Cavalli, Franco (Institute of Oncology Research, Bellinzona, Switzerland; and.) ; Zucca, Emanuele (International Extranodal Lymphoma Study Group, Bellinzona, Switzerland) ; Rossi, Davide (Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) ; Universitat Autònoma de Barcelona
Splenic marginal zone B-cell lymphoma (SMZL) is a heterogeneous clinico-biological entity. The clinical course is variable, multiple genes are mutated with no unifying mechanism, and essential regulatory pathways and surrounding microenvironments are diverse. [...]
2022 - 10.1182/blood.2021012386
Blood, Vol. 139 Núm. 5 (february 2022) , p. 732-747  
2.
15 p, 3.6 MB Unraveling the genetics of transformed splenic marginal zone lymphoma / Grau, Marta (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; López, Cristina (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Navarro, Alba (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Frigola, Gerard (Hospital Clínic i Provincial de Barcelona) ; Nadeu, Ferran (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Clot, Guillem (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Bastidas-Mora, Gabriela (Hospital Clínic i Provincial de Barcelona) ; Alcoceba, Miguel (Hospital Universitario de Salamanca) ; Baptista, Maria Joao (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Blanes, Margarita (Hospital General Universitario de Elda) ; Colomer, Dolors (Hospital Clínic i Provincial de Barcelona) ; Costa, Dolors (Hospital Clínic i Provincial de Barcelona) ; Domingo-Domenech, Eva (Institut d'Investigació Biomèdica de Bellvitge) ; Enjuanes, Anna (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Escoda, Lourdes (Hospital Universitari Joan XXIII de Tarragona) ; Forcada, Pilar (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Giné, Eva (Hospital Clínic i Provincial de Barcelona) ; Lopez-Guerra, Mónica (Hospital Clínic i Provincial de Barcelona) ; Ramón, Olga (Hospital General de Igualada) ; Rivas-Delgado, Alfredo (Hospital Clínic i Provincial de Barcelona) ; Folch, Laura Vicente (Consorci Sanitari de Terrassa) ; Wotherspoon, Andrew (Royal Marsden NHS Foundation Trust, United Kingdom) ; Climent, Fina (Institut d'Investigació Biomèdica de Bellvitge) ; Campo, Elias (Hospital Clínic i Provincial de Barcelona) ; López-Guillermo, Armando (Hospital Clínic i Provincial de Barcelona) ; Matutes, Estella (Hospital Clínic i Provincial de Barcelona) ; Bea, Sílvia (Hospital Clínic i Provincial de Barcelona)
The genetic mechanisms associated with splenic marginal zone lymphoma (SMZL) transformation are not well defined. We studied 41 patients with SMZL that eventually underwent large B-cell lymphoma transformation. [...]
2023 - 10.1182/bloodadvances.2022009415
Blood advances, Vol. 7 Núm. 14 (july 2023) , p. 3695-3709  
3.
10 p, 2.0 MB Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets / Karube, K. (University of the Ryukyus) ; Enjuanes, A. (Hospital Clínic i Provincial de Barcelona) ; Dlouhy, I. (Hospital Clínic i Provincial de Barcelona) ; Jares, Pedro (Hospital Clínic i Provincial de Barcelona) ; Martín-García, David (Hospital Clínic i Provincial de Barcelona) ; Nadeu, Ferran (Hospital Clínic i Provincial de Barcelona) ; Ordóñez, G.R. (DREAMgenics) ; Rovira, Jordi (Hospital Clínic i Provincial de Barcelona) ; Clot, Guillem (Hospital Clínic i Provincial de Barcelona) ; Royo, C. (Hospital Clínic i Provincial de Barcelona) ; Navarro, A. (Hospital Clínic i Provincial de Barcelona) ; Gonzalez-Farre, B. (Hospital Clínic i Provincial de Barcelona) ; Vaghefi, A. (Hospital Clínic i Provincial de Barcelona) ; Castellano, G. (Hospital Clínic i Provincial de Barcelona) ; Rubio-Perez, C. (Universitat Pompeu Fabra) ; Tamborero, D. (Universitat Pompeu Fabra) ; Briones Meijide, Javier (Institut d'Investigació Biomèdica Sant Pau) ; Salar, A. (Hospital del Mar (Barcelona, Catalunya)) ; Sancho, J.M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Mercadal, S. (ICO-Hospital Duran i Reynals) ; Gonzalez-Barca, E. (ICO-Hospital Duran i Reynals) ; Escoda, L. (Hospital Universitari Joan XXIII de Tarragona) ; Miyoshi, H. (Kurume University School of Medicine) ; Ohshima, K. (Kyushu University) ; Miyawaki, K. (Kyushu University) ; Kato, K. (Kyushu University) ; Akashi, K. (Kyushu University) ; Mozos, Ana (Institut d'Investigació Biomèdica Sant Pau) ; Colomo, L. (Hospital del Mar (Barcelona, Catalunya)) ; Alcoceba, Miguel (Hospital Universitario de Salamanca) ; Valera, A. (Hospital Clínic i Provincial de Barcelona) ; Carrió, A. (Hospital Clínic i Provincial de Barcelona) ; Costa, D. (Institució Catalana de Recerca i Estudis Avançats) ; Lopez-Bigas, N. (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ; Schmitz, R. (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ; Staudt, L.M. (Hospital Clínic i Provincial de Barcelona) ; Salaverria, I. (Hospital Clínic i Provincial de Barcelona) ; López-Guillermo, A. (Hospital Clínic i Provincial de Barcelona) ; Campo, E. (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Genome studies of diffuse large B-cell lymphoma (DLBCL) have revealed a large number of somatic mutations and structural alterations. However, the clinical significance of these alterations is still not well defined. [...]
2018 - 10.1038/leu.2017.251
Leukemia, Vol. 32 Núm. 3 (january 2018) , p. 675-684  
4.
12 p, 600.5 KB A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma / Carlo-Stella, Carmelo (Humanitas Research Hospital (Itàlia)) ; Zinzani, Pier Luigi (IRCCS Azienda Ospedaliero-Universitaria di Bologna) ; Sureda, Anna (Hospital Universitari de Bellvitge) ; Araújo, Luis (Universitário de Coimbra) ; Casasnovas, Olivier (CHU Dijon Bourgogne) ; Carpio Segura, Cecilia del Carmen (Hospital Universitari Vall d'Hebron) ; Yeh, Su-Peng (China Medical University Hospital) ; Bouabdallah, Krimo (University Hospital of Bordeaux) ; Cartron, Guillaume (Centre Hospitalier Universitaire Montpellier) ; Kim, Won Seog (Samsung Medical Center) ; Cordoba, Raul (Hospital Universitario Fundación Jiménez Díaz) ; Koh, Youngil (Seoul National University Hospital) ; Re, Alessandro (ASST Spedali Civili Brescia) ; Alves, Daniela (Centro Hospitalar Universitário Lisboa Norte) ; Chamuleau, Martine (Vrije Universiteit Amsterdam) ; Le Gouill, Steven (Institut Curie) ; López Guillermo, Armando (Hospital Clínic i Provincial de Barcelona) ; Moreira, Ilídia (Portuguese Institute of Oncology of Porto) ; van der Poel, Marjolein W. M. (Maastricht University Medical Center) ; Abbadessa, Giovanni (Sanofi) ; Meng, Robin (Sanofi) ; Ji, Ran (Sanofi) ; Lépine, Lucie (Sanofi) ; Saleem, Rao (Sanofi) ; Ribrag, Vincent (Institut Gustave Roussy (Villejuif, França)) ; Universitat Autònoma de Barcelona
Patients with relapsed or refractory lymphoma have limited treatment options, requiring newer regimens. In this Phase 1/2 study (NCT03769181), we assessed the safety, efficacy, and pharmacokinetics of isatuximab (Isa, anti-CD38 antibody) in combination with cemiplimab (Cemi, anti-programmed death-1 [PD-1] receptor antibody; Isa + Cemi) in patients with classic Hodgkin lymphoma (cHL), diffuse large B-cell lymphoma (DLBCL), and peripheral T-cell lymphoma (PTCL). [...]
2022 - 10.1002/hon.3089
Hematological Oncology, Vol. 41 (october 2022) , p. 108-119  
5.
18 p, 2.5 MB The EHA Research Roadmap : Malignant Lymphoid Diseases / Dreyling, Martin (LMU Hospital (Alemanya)) ; André, Marc (Université Catholique de Louvain (bèlgica)) ; Gökbuget, Nicola (Goethe University (Alemanya)) ; Tilly, Hervé (Centre Henri Becquerel and Université de Rouen (França)) ; Jerkeman, Mats (Skåne University and Lund University (Suècia)) ; Gribben, John (Queen Mary University of London (Regne Unit)) ; Ferreri, Andrés (IRCCS San Raffaele Scientific Institute (Itàlia)) ; Morel, Pierre (CHU Amiens Picardie (França)) ; Stilgenbauer, Stephan (Universität Ulm (Alemanya)) ; Fox, Christopher (University of Nottingham (Regne Unit)) ; Maria Ribera, José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Zweegman, Sonja (Amsterdam UMC (Països Baixos)) ; Aurer, Igor (University of Zagreb (Zagreb)) ; Bödör, Csaba (Semmelweis University (Hongria)) ; Burkhardt, Birgit (Pädiatrische Hämatologie und Onkologie (Alemanya)) ; Buske, Christian (University Hospital of Ulm (Alemanya)) ; Dollores Caballero, Maria (El Instituto de Investigación Biomédica de Salamanca (Salamanca, Espanya)) ; Campo, Elias (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Chapuy, Bjoern (Berlin Institute of Health (Alemanya)) ; Davies, Andrew (University of Southampton (Regne Unit)) ; de Leval, Laurence (Lausanne University Switzerland (Suïssa)) ; Doorduijn, Jeanette (University Medical Center Rotterdam the Netherlands (Països Baixos)) ; Federico, Massimo (GVM Care & Research (Itàlia)) ; Gaulard, Philippe (Hôpital Henri Mondor (França)) ; Gay, Francesca (AOU Città Della Salute e Della Scienza (Itàlia)) ; Ghia, Paolo (IRCCS Ospedale San Raffaele (Itàlia)) ; Grønbæk, Kirsten (University of Copenhagen (Dinamarca)) ; Goldschmidt, Hartmut (University Hospital Heidelberg (Alemanya)) ; Kersten, Marie-Jose (Cancer Center Amsterdam and LYMMCARE the Netherlands (Països Baixos)) ; Kiesewetter, Barbara (Medical University of Vienna (Àustria)) ; Landman-Parker, Judith (Sorbonne Université APHP/hôpital A Trousseau (França)) ; Le Gouill, Steven (Clinique du Centre Hospitalier Universitaire (CHU) de Nantes (França)) ; Lenz, Georg (Medical University Hospital Münster (Alemanya)) ; Leppä, Sirpa (Helsinki University Hospital Comprehensive Cancer Centre Finland (Finlandia)) ; López Guillermo, Armando (Hospital Clínic i Provincial de Barcelona) ; Macintyre, Elizabeth (Assistance Publique-Hôpitaux de Paris (França)) ; Mantega, Maria Victoria Mateos (Universidad de Salamanca (Salamanca, Espanya)) ; Moreau, Philippe (University Hospital Hotel-Dieu (França)) ; Moreno, Carol (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Nadel, Bertrand (Aix Marseille Univ (França)) ; Okosun, Jessica (Queen Mary University of London (Regne Unit)) ; Owen, Roger (St James's Institute of Oncology (Regne Unit)) ; Pospisilova, Sarka (University Hospital Brno (Txèquia)) ; Pott, Christiane (Universitätsklinikum Schleswig-Holstein (Alemanya)) ; Robak, Tadeusz (Medical University of Lodz (Polònia)) ; Spina, Michelle (National Cancer Institute (Itàlia)) ; Stamatopoulos, Kostas (Centre for Research and Technology Hellas Greece (Grècia)) ; Stary, Jan (Charles University Prague University Hospital Czech Republic (Txèquia)) ; Tarte, Karin (Immunology and Cell Therapy Lab at Rennes University Hospital (França)) ; Tedeschi, Allessandra (Niguarda Hospital Milano (Itàlia)) ; Thieblemont, Catherine (Assistance Publique-Hôpitaux de Paris (França)) ; Trappe, Ralf Ulrich (DIAKO Hospital Bremen (Alemanya)) ; Trümper, Lorenz H. (University Medicine Goettingen (Alemanya)) ; Salles, Gilles (Weill Cornell Medicine (Estats Units)) ; Universitat Autònoma de Barcelona
2022 - 10.1097/HS9.0000000000000726
HemaSphere, Vol. 6 (may 2022)  
6.
1 p, 80.2 KB Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation / Dlouhy, Ivan (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Armengol, Marc Antoni (Universitat Autònoma de Barcelona) ; Recasens-Zorzo, Clara (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Ribeiro, Marcelo L. (Universidade São Francisco) ; Pérez-Galán, Patricia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Bosch José, Francesc Xavier 1947- (Vall d'Hebron Institut d'Oncologia) ; López Guillermo, Armando (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Roué, Gaël (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
2022 - 10.3324/haematol.2022.281988
Haematologica, Vol. 107 (december 2022) , p. 2990  
7.
7 p, 5.6 MB Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter's Transformation / Ortiz-Maldonado, Valentín (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Frigola, Gerard (Hospital Clínic i Provincial de Barcelona) ; Español-Rego, Marta (Hospital Clínic i Provincial de Barcelona) ; Balagué, Olga (Hospital Clínic i Provincial de Barcelona) ; Martínez Cibrián, Núria (Hospital Clínic i Provincial de Barcelona) ; Magnano, Laura (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Giné, Eva (Centro de Investigación Biomédica en Red de Cáncer) ; Pascal, Mariona (Hospital Clínic i Provincial de Barcelona) ; Correa, Juan G. (Hospital Clínic i Provincial de Barcelona) ; Martínez-Roca, Alexandra (Hospital Clínic i Provincial de Barcelona) ; Cid, Joan (Hospital Clínic i Provincial de Barcelona) ; Lozano, Miquel (Universitat de Barcelona. Departament de Medicina) ; Villamor, Neus (Hospital Clínic i Provincial de Barcelona) ; Benítez Ribas, Daniel (Hospital Clínic i Provincial de Barcelona) ; Esteve Reyner, Jordi (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; López Guillermo, Armando (Universitat de Barcelona. Departament de Medicina) ; Campo, Elias (Hospital Clínic i Provincial de Barcelona) ; Urbano Ispizua, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Juan, Manel (Universitat de Barcelona. Departament de Medicina) ; Delgado, Julio (Universitat de Barcelona. Departament de Medicina)
CART19 cells are emerging as an alternative therapy for patients with chronic lymphocytic leukemia (CLL). Here we report the outcome of nine consecutive patients with CLL treated with ARI-0001 CART19 cells, six of them with Richter's transformation (RT). [...]
2022 - 10.3389/fonc.2022.828471
Frontiers in Oncology, Vol. 12 (31 2022) , p. 828471  
8.
10 p, 4.1 MB Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation / Bastidas-Mora, Gabriela (Hospital Clínic i Provincial de Barcelona) ; Bea, Sílvia (Centro de Investigación Biomédica en Red de Cáncer) ; Navarro, Alba (Centro de Investigación Biomédica en Red de Cáncer) ; Gine, Eva (Centro de Investigación Biomédica en Red de Cáncer) ; Costa, Dolors (Centro de Investigación Biomédica en Red de Cáncer) ; Delgado, Julio (Centro de Investigación Biomédica en Red de Cáncer) ; Baumann, Tycho (Hospital Universitario 12 de Octubre (Madrid)) ; Magnano, Laura (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Rivas-Delgado, Alfredo (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Villamor, Neus (Centro de Investigación Biomédica en Red de Cáncer) ; Colomer, Dolors (Centro de Investigación Biomédica en Red de Cáncer) ; Lopez-Guerra, Mónica (Centro de Investigación Biomédica en Red de Cáncer) ; Rozman, María (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Balagué, Olga (Centro de Investigación Biomédica en Red de Cáncer) ; Martínez, Daniel (Centro de Investigación Biomédica en Red de Cáncer) ; Baptista, Maria Joao (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Escoda, Lourdes (Hospital Universitari Joan XXIII de Tarragona) ; Alcoceba, Miguel (Hospital Universitario de Salamanca) ; Blanes, Margarita (Hospital General Universitario de Elda) ; Climent, Fina (Institut d'Investigació Biomèdica de Bellvitge) ; Campo, Elias (Centro de Investigación Biomédica en Red de Cáncer) ; Wotherspoon, Andrew (The Royal Marsden NHS Foundation Trust) ; López Guillermo, Armando (Centro de Investigación Biomédica en Red de Cáncer) ; Matutes, Estella (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
We describe 36 patients with splenic marginal zone lymphoma (SMZL) with transformation (SMZL-T), including 15 from a series of 84 patients with SMZL diagnosed at the Hospital Clinic of Barcelona (HCB) and 21 diagnosed with SMZL-T in other centres. [...]
2022 - 10.1111/bjh.17815
British Journal of Haematology, Vol. 196 Núm. 1 (january 2022) , p. 146-155  
9.
5 p, 964.3 KB Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation / Dlouhy, Ivan (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Armengol, Marc Antoni (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Recasens-Zorzo, Clara (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Ribeiro, Marcelo L. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Pérez-Galán, Patricia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Bosch José, Francesc Xavier 1947- (Vall d'Hebron Institut d'Oncologia) ; López Guillermo, Armando (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Roué, Gaël (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
2021 - 10.3324/haematol.2020.278258
Haematologica, Vol. 106 Núm. 10 (october 2021) , p. 2749-2753  
10.
11 p, 1.9 MB Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma / Recasens-Zorzo, Clara (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Cardesa-Salzmann, Teresa (Hospital Clínic i Provincial de Barcelona) ; Petazzi, Paolo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ros-Blanco, Laia (Universitat Ramon Llull. Institut Químic de Sarrià-IQS) ; Esteve-Arenys, Anna (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Clot, Guillem (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Guerrero-Hernández, Martina (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Rodríguez, Vanina (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Soldini, Davide (Hospital Clínic i Provincial de Barcelona) ; Valera, Alexandra (Hospital Clínic i Provincial de Barcelona) ; Moros, Alexandra (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Climent, Fina (Hospital Universitari de Bellvitge) ; Gonzalez-Barca, Eva (Institut Català d'Oncologia) ; Mercadal, Santiago (Institut Català d'Oncologia) ; Arenillas, Leonor (Institut Hospital del Mar d'Investigacions Mèdiques) ; Calvo, Xavier (Institut Hospital del Mar d'Investigacions Mèdiques) ; Mate Sanz, Jose Luís (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gutiérrez-García, Gonzalo (Hospital Clínic i Provincial de Barcelona) ; Casanova Rigat, Isolda (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Mangues, Ramon 1957- (Institut d'Investigació Biomèdica Sant Pau) ; Sanjuan-Pla, Alejandra (Hospital Universitari i Politècnic La Fe (València)) ; Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Martínez, Antonio (Hospital Clínic i Provincial de Barcelona) ; Colomer, Dolors (Hospital Clínic i Provincial de Barcelona) ; Estrada Tejedor, Roger (Universitat Ramon Llull) ; Teixidó, Jordi (Universitat Ramon Llull) ; Campo, Elias (Hospital Clínic i Provincial de Barcelona) ; López-Guillermo, A. (Hospital Clínic i Provincial de Barcelona) ; Borrell, José Ignacio (Universitat Ramon Llull) ; Colomo, Luis (Institut Hospital del Mar d'Investigacions Mèdiques) ; Pérez-Galán, Patricia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Roué, Gaël (Vall d'Hebron Institut d'Oncologia) ; Universitat Autònoma de Barcelona
Constitutive activation of the chemokine receptor CXCR4 has been associated with tumor progression, invasion, and chemotherapy resistance in different cancer subtypes. Although the CXCR4 pathway has recently been suggested as an adverse prognostic marker in diffuse large B-cell lymphoma, its biological relevance in this disease remains underexplored. [...]
2019 - 10.3324/haematol.2017.180505
Haematologica, Vol. 104 Núm. 4 (31 2019) , p. 778-788  

Articles : 12 records found   1 - 10next  jump to record:
See also: similar author names
5 Lopez-Guillermo, Armando
5 López-Guillermo, A.
5 López-Guillermo, Armando
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.